0001636098-16-000003.txt : 20160106 0001636098-16-000003.hdr.sgml : 20160106 20160106160019 ACCESSION NUMBER: 0001636098-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 EFFECTIVENESS DATE: 20160106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Geneius Biotechnology, Inc. CENTRAL INDEX KEY: 0001636098 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254652 FILM NUMBER: 161326781 BUSINESS ADDRESS: STREET 1: 12 MICHIGAN DRIVE CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 781-856-7589 MAIL ADDRESS: STREET 1: 12 MICHIGAN DRIVE CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0707 D LIVE 0001636098 Geneius Biotechnology, Inc. 12 MICHIGAN DRIVE NATICK MA MASSACHUSETTS 01760 781-856-7589 DELAWARE None None Corporation true 2015 Alfred Slanetz c/o Geneius Biotechnology, Inc. 12 Michigan Drive Natick MA MASSACHUSETTS 01760 Executive Officer Director Ryan Lane c/o Geneius Biotechnology, Inc. 12 Michigan Drive Natick MA MASSACHUSETTS 01760 Director Biotechnology Decline to Disclose 06b false 2015-12-23 false true false 0 Roth Capital Partners 15407 None None 888 San Clemente Drive Newport Beach CA CALIFORNIA 92660 AR ARKANSAS CA CALIFORNIA MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK OK OKLAHOMA false 2387350 2387350 0 false 20 70000 true 0 Roth Capital Partners was compensated through issuance of $70,000 in Notes and warrants to purchase an aggregate of 36,892 shares of the Issuers common stock, par value $0.001 per share. 0 false Geneius Biotechnology, Inc. /s/ Alfred Slanetz Alfred Slanetz President and Chief Executive Officer 2016-01-06